Between 10 and 14 April 2022, the Smart Blood Analytics Swiss SA scientific and development teams attended EuroMedLab 2021 in Munich. EuroMedLab 2021 combined the 24^th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine and the National Congress of the German Society of Clinical Chemistry and Laboratory Medicine. The congress aimed to bring together scientists, laboratory specialists, clinicians, and industry colleagues in clinical chemistry and laboratory medicine to enable scientific exchange. 

The congress was composed of scientific programs, educational workshops, poster sessions, and the IVD industry exhibition demonstrating the latest technological advancements and breakthroughs in diagnostic laboratory technology. The SBAS team paid special attention to artificial intelligence in laboratory testing, data science, and healthcare transformation through clinical decision support. After fruitful discussions with leaders in the IVD sector, it is clear that there is a world-wide need for innovative and reliable clinical decision support (CDS) systems, such as SBAS Software and mySmartBlood. With SBAS clinical decision support solutions, diagnostic processes can be significantly improved by enabling doctors to make more accurate and quicker decisions with better patient outcomes and with reduced costs for healthcare systems. 

This was the first major IFCC/EFLM conference held following a long delay caused by the COVID-19 pandemic. It was a pleasure to discover and learn about the latest innovations in clinical laboratory science and the SBAS team enjoyed networking and meeting with other participants.